|Bid||4.3000 x 1400|
|Ask||4.4700 x 3200|
|Day's range||4.3850 - 4.6300|
|52-week range||2.5200 - 12.8900|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||09 Aug 2022 - 15 Aug 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||4.95|
The catalyst that sent the telehealth software company higher was bullish commentary courtesy of a Wall Street analyst. Piper Sandler analyst Sean Wieland raised his price target on American Well (also called Amwell) to $6, up from its previous level of $5. The analyst cited numerous client wins, including the recent signing of CVS Health (NYSE: CVS), which he sees as "marquee reference customers."
Among the hottest stocks last month was Amwell (NYSE: AMWL). It was shortly after the company reported earnings last month that Amwell's stock started to gain momentum. For the first three months of 2022, Amwell posted sales of $64.2 million which rose 12% year over year.
BOSTON, June 08, 2022--Amwell appoints Dr. Carrie Nelson to the role of Chief Medical Officer.